Table 2. Comparison of baseline clinical, echocardiographic, laboratory and procedural variables between patients with and without ERAF.
No ERAF n = 42 | ERAF n = 26 | |
Age (years) | 58±12 | 62±9 |
Males/females (%) | 69/31 | 58/42 |
Lone AF (%) | 67 | 65 |
Paroxysmal AF/persistent AF (%) | 62/38 | 54/46 |
AF history (months) | 74±63 | 70±58 |
Body mass index (kg/m2) | 28±4 | 30±4 |
Statins (%) | 29 | 27 |
ACEI/ARB (%) | 64 | 69 |
LVEF (%) | 59±9 | 60±9 |
LAD (mm)* | 42±6 | 45±6 |
Total ablation duration (min) | 38±17 | 43±22 |
Total ablation power (J) | 74.030±30.220 | 84.721±42.743 |
hs-CRP (µg/ml) at baseline | 2.03±1.10 | 2.11±1.10 |
p<0.05; all other variables not significant.
Abbreviations as in Table 1.